Markedsdata leveret af TwelveData og Morningstar
Zhejiang Hisun Pharmaceutical Co., Ltd. is a leading player in the pharmaceutical industry, primarily focusing on the research, development, manufacture, and sale of pharmaceutical products globally. Established in China, Hisun Pharmaceutical is renowned for its extensive portfolio, which includes antibiotics, antineoplastic drugs, cardiovascular agents, and animal health products. The company plays a crucial role in the healthcare sector, leveraging advanced biotechnology and chemical synthesis to enhance drug formulations and meet global health standards. Hisun Pharmaceutical serves various markets by distributing its products to healthcare providers, hospitals, and pharmacies around the world. It has strategic partnerships and collaborations with other pharmaceutical giants, enabling it to expand its market reach and foster innovation. As a publicly traded entity, Zhejiang Hisun Pharmaceutical is integral to the health and pharmaceutical sectors, frequently contributing to both preventive and curative healthcare solutions. The company's commitment to quality and innovation has solidified its status as a key contributor to pharmaceutical advancements.